Facile Preparation of (2Z,4E)-Dienamides by the Olefination of Electron-deficient Alkenes with Allyl Acetate
June 21st, 2017
The ruthenium-catalyzed olefination of electron-deficient alkenes with allyl acetate is described here. By using aminocarbonyl as a directing group, this external oxidant-free protocol has high efficiency and good stereo- and regioselectivity, opening a novel synthetic route to (Z,E)-butadiene skeletons.
The overall goal of this ruthenium catalyzed and oxidant free protocol is to synthesize Z, E-butadienes by olefination of electron-deficient alkenes using aminocarbonyl as a directing group. This method that can help answer key questions in a C-H bound functionalization, such as the olifination of alkenes using allyl acetate. The main advantage of this technique is that Z, E-butadiene can be obtained directly from acrylic amide and allyl acetate result in antioxidant using inexpensive ruthenium in catalyst.
Demonstrating the procedure will be Chunbing Yu, a graduate student in our laboratory;Prior to starting this procedure, dry an eight milliliter screw cap reaction vial with a compatible magnetic stir bar in an oven at 120 degrees Celsius for over two hours. After removing the vial from the oven, cool it to room temperature with inert gas before use. Using an analytical balance, weigh 3.7 milligrams of ruthenium cyme chloride dimer and 13.7 milligrams of silver hexafluoroantimonate into the reaction vial.
Next, add one milliliter of dry 1, 2-dicholoroethane to the reaction viae. Using the analytical balance, weigh 0.2 millimoles of acrylamide into the reaction vial. Then, add 43 microliters of allyl acetate to the reaction vial with a micro syringe.
Following this, blanket the reaction vial with argon and immediately cover it with a compatible screw cap. Stir the reaction mixture at room temperature for five minutes. Then heat the reaction mixture to 110 degrees Celsius in an oil bath with stirring for 16 to 18 hours.
After cooling the vial down, use thin layer chromatography or TLC, to monitor the progress of the reaction by comparing the reaction mixture to an acrylamide standard. Use a 1:2 ratio of ethyl acetate and petroleum ether to develop the TLC plate. Now dissolve the crude product in a minimum volume of dichloromethane and load it onto a silica gel column wet with petroleum ether.
Separate the cross coupling products by column chromatography, using a mixture of ethyl acetate and petroleum ether as the eluent. After connecting the eluent containing product in a flask, evaporate the solvent on a rotary evaporator. Then place the flask under a high vacuum for a minimum of two hours to obtain 20 to 50 milligrams of product for characterization by NMR spectroscopy.
The optimization of conditions for the preparation of 1, 3-butadiene, including the screening of various additives and solvents, using your ruthenium cymene chloride dimer as the catalyst is shown here. The scope of the reaction was explored by submitting various acrylamides to the optimized conditions in the presence of allyl acetate 2a. Modest to excellent yields were obtained with good ratio selectivity and alkene selectivity.
The reactivity of different allyl derivatives and branched allyl acetates, was also examined. Alpha and beta substituted allyl acetates were completely inert for cross coupling. While gamma substituted allyl acetate afforded only trace product.
Other allyl carboxylic esters showed decreased reactivity compared to allyl acetate 2a. And allyl methyl carbonate 2f was more inactive, forming product in 24%yield. To investigate the reaction mechanism, two deuterium labeled experiments were conducted.
When acrylamide 1g was subjected to a standard catalytic system in the presence of acetic acid D4, the cationic ruthenium species led to a Z selective hydrogen deuterium exchange on a acrylamide, indicating a reversible cyclometalation event. Moreover, a kinetic isotope effect of 3.2 was observed in the intermolecular isotopic study, suggesting that the olefinic carbon-hydrogen bond metalation step, is probably involved in the rate determining step.
View the full transcript and gain access to thousands of scientific videos
Overview
This article describes a ruthenium-catalyzed olefination method for synthesizing (Z,E)-butadienes from electron-deficient alkenes using allyl acetate. The protocol employs aminocarbonyl as a directing group, achieving high efficiency and selectivity without the need for external oxidants.
Key Study Components
Area of Science
- Chemistry
- Organic Synthesis
- Catalysis
Background
- Olefination is a key reaction in organic synthesis.
- Electron-deficient alkenes are challenging substrates for olefination.
- Ruthenium catalysts are known for their effectiveness in various reactions.
- Directing groups can enhance selectivity in C-H functionalization.
Purpose of Study
- To develop an efficient method for synthesizing (Z,E)-butadienes.
- To utilize aminocarbonyl as a directing group in olefination.
- To demonstrate a protocol that is oxidant-free and cost-effective.
Methods Used
- Ruthenium-catalyzed olefination reaction.
- Use of allyl acetate as a reagent.
- Preparation of reaction vials under inert conditions.
- Weighing and mixing of catalyst components.
Main Results
- Successful synthesis of (Z,E)-butadienes from acrylic amide and allyl acetate.
- High efficiency and selectivity observed in the reactions.
- Demonstration of the method by a graduate student.
- Cost-effective use of ruthenium as a catalyst.
Conclusions
- The developed method provides a novel synthetic route for (Z,E)-butadienes.
- Utilizing aminocarbonyl as a directing group enhances reaction outcomes.
- This protocol is a significant advancement in C-H functionalization techniques.
Frequently Asked Questions
Executive Industry Relevance
This method enables direct synthesis of Z,E-butadienes from electron-deficient alkenes using aminocarbonyl as a directing group, offering a step-economical route to bioactive diene scaffolds. By eliminating external oxidants and employing inexpensive ruthenium catalysis, the process reduces waste and operational complexity in early-stage medicinal chemistry. The high stereoselectivity and broad substrate scope support rapid exploration of structure-activity relationships in butadiene-containing lead candidates.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables rapid generation of Z,E-butadiene motifs for probing structure-activity relationships in target validation assays.
- Operational Value: Provides a reliable, oxidant-free protocol for producing defined stereoisomers, reducing isomer separation burden in hit-to-lead optimization.
Screening & Assay Development
- Scientific Value: Delivers consistent (Z,E)-dienamide products with high purity, enabling reproducible compound screening against biological targets.
- Operational Value: Uses inexpensive ruthenium catalyst and avoids chromatographic purification bottlenecks through high-yielding, selective transformations.
Translational & Preclinical Research
- Scientific Value: Supports synthesis of dienamide intermediates for preclinical candidate development where butadiene pharmacophores modulate target engagement.
- Operational Value: Compatible with diverse N-substituted acrylamides, allowing parallel synthesis of analog libraries for ADME/toxicity profiling.
Pipeline & Workflow Integration
The method fits within early discovery workflows, enabling rapid access to butadiene scaffolds for lead identification and supporting iterative design-make-test cycles in medicinal chemistry programs.
- Discovery Biology: Facilitates hypothesis testing by providing stereodefined dienamide probes to interrogate target binding pockets and structure-function relationships.
- Screening: Generates quantifiable, pure (Z,E)-dienamide outputs suitable for high-concentration screening campaigns requiring consistent compound quality.
- Analytics: Produces isolable products amenable to NMR and LC-MS characterization, enabling confident compound tracking and purity assessment.
- Translational Research: Connects to preclinical work by supplying dienamide building blocks for SAR exploration in disease-relevant models.
- Enterprise Reuse: Establishes a reusable catalytic platform for butadiene synthesis across multiple projects, reducing re-optimization effort.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence through stereoselective formation of bioactive diene motifs, reducing mechanistic ambiguity in SAR interpretation.
- Operational Value: Delivers high yields (up to 80%) with minimal waste, improving material efficiency and reducing purification timelines.
- Strategic Value: Enables faster go/no-go decisions by providing rapid access to diverse butadiene analogs for target engagement studies.
- Portfolio Impact: Supports risk-adjusted prioritization through reliable, scalable access to synthetically challenging diene scaffolds.
Implementation Considerations
- Requires expertise in organometallic catalysis and air-sensitive techniques for handling ruthenium catalysts and silver salts.
- Necessitates inert atmosphere capability (argon or nitrogen) and oil bath heating to 110 °C for 16–18 hours.
- Demands access to analytical TLC and column chromatography infrastructure for reaction monitoring and product purification.
- Involves consideration of substrate scope limitations, as gamma-substituted allyl acetates show poor reactivity.
- Requires optimization of solvent (DCE) and catalyst loading ([Ru(p-cymene)Cl₂]₂ at 3 mol %, AgSbF₆ at 20 mol %) for consistent results across laboratories.
